Navigation Links
Pro-Dex, Inc. Announces Fiscal 2012 First Quarter Results
Date:11/9/2011

IRVINE, Calif., Nov. 9, 2011 /PRNewswire/ -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for its fiscal first quarter ended September 30, 2011.

(Logo:  http://photos.prnewswire.com/prnh/20111025/LA93174LOGO-c)

Sales for the quarter ended September 30, 2011 were $6.0 million, 3% higher than sales of $5.8 million for the corresponding quarter in 2010, due primarily to increases in sales of the Company's medical device products and fractional horsepower motors.  

Operating income was $457,000 for the quarter, a 13% increase from operating income of $405,000 in the corresponding 2010 period.  

Net income for the quarter was $446,000, or $0.14 per diluted share, which represents a 30% improvement from net income of $342,000, or $0.10 per diluted share in the corresponding 2010 quarter.Gross profit for the quarter ended September 30, 2011 increased to $2.3 million, a 38% gross profit margin, compared to gross profit of $2.2 million, a 37% gross profit margin, for the same year-ago period. Mark Murphy, the Company's President and Chief Executive Officer, commented, "We were pleased with our operating results this quarter.  Medical device sales remained strong as increased year-over-year sales to our second-largest customer more than offset decreased year-over-year sales to our largest customer.  In addition, we were happy to see an increase in sales of our fractional horsepower motors.  While these results are pleasing, our focus remains on the diversification of our revenue base.  In the process, we continue to control expenses and strengthen our balance sheet, as we generated $349,000 of operating cash during the quarter."  

Teleconference Information:Investors and analysts are invited to listen to a broadcast review of the Company's fiscal 2012 first quarter financial results today at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time) that may be accessed by visiting the Company's website at www.pro-dex.com.  The conference call may also be accessed at www.InvestorCalendar.com. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S.

For those who cannot access the live broadcast, a replay will be available approximately two hours after the completion of the call until midnight (Eastern Time) on November 22, 2011 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S., and then entering account number 286 and conference I.D. number 382391.  An online archive of the broadcast will be available on the Company's website www.pro-dex.com for a period of 365 days.

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate powered surgical device drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.  For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.

(tables follow)PRO-DEX, INC. and SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(unaudited)September 30, 2011June 30, 2011ASSETSCurrent assets:Cash and cash equivalents

$4,907,000

$4,689,000Accounts receivable, net of allowance for doubtful accountsof $8,000 at September 30, 2011 and $7,000 at June 30, 2011

2,330,000

3,128,000Other receivables

24,000

12,000Inventories

4,041,000

3,703,000Prepaid expenses

264,000

145,000Deferred income taxes

162,000

163,000Total current assets

11,728,000

11,840,000Property, plant, equipment and leasehold improvements, net

3,534,000

3,661,000Other assets

53,000

60,000Total assets

$15,315,000

$15,561,000LIABILITIES AND SHAREHOLDERS' EQUITYCurrent liabilities:Accounts payable

$1,163,000

$1,207,000Accrued expenses

1,804,000

2,379,000Income taxes payable

80,000

78,000Current portion of bank term loan

357,000

357,000Total current liabilities

3,404,000

4,021,000Non-current liabilities:Bank term loan

685,000

774,000Deferred income taxes

162,000

163,000Deferred rent

282,000

279,000Total non-current liabilities

1,129,000

1,216,000Total liabilities

4,533,000

5,237,000Commitments and contingencies Shareholders' equity:Common shares; no par value; 50,000,000 shares authorized;3,272,350 shares issued and outstanding at September 30, 2011and at June 30, 2011

16,756,000

16,744,000Accumulated deficit

(5,974,000)

(6,420,000)Total shareholders' equity

10,782,000

10,324,000Total liabilities and shareholders' equity

$15,315,000

$15,561,000PRO-DEX INC. and SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF INCOME(unaudited)For The Three Months Ended September 30,20112010Net sales

$6,030,000

$5,829,000Cost of sales

3,701,000

3,645,000Gross profit

2,329,000

2,184,000Operating expenses:Selling expenses

374,000

424,000General and administrative expenses

836,000

764,000Research and development costs

662,000

591,000Total operating expenses

1,872,000

1,779,000Income from operations

457,000

405,000Other income (expense):Interest expense, net

(10,000)

(57,000)Total other income (expense)

(10,000)

(57,000)Income before provision for income taxes

447,000

348,000Provision for income taxes

1,000

6,000Net income

$446,000

$342,000Net income per share:Basic

$0.14

$0.11Diluted

$0.14

$0.10Weighted average shares outstanding - basic

3,272,350

3,251,850Weighted average shares outstanding - diluted

3,280,045

3,263,366PRO-DEX, INC. and SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(unaudited)For The Three Months Ended September 30,20112010Cash flows from operating activities: Net income

$446,000

$342,000 Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization

169,000

172,000Allowance for doubtful accounts

1,000

(12,000)Stock based compensation

12,000

4,000Deferred taxes

-

(18,000)Changes in:Accounts receivable

785,000

(18,000)Inventories

(338,000)

(621,000)Prepaid expenses

(119,000)

(36,000)Other assets

8,000

17,000Accounts payable and accrued expenses

(616,000)

582,000Income taxes payable

1,000

(31,000)Net cash provided by operating activities

349,000

381,000Cash flows from investing activities: Purchases of equipment and leasehold improvements

(42,000)

(6,000)Net cash used in investing activities

(42,000)

(6,000)Cash flows from financing activities:Principal payments on term loan

(89,000)

(100,000)Principal payments on mortgage

-

(1,528,000)Net cash used by financing activities

(89,000)

(1,628,000)Net increase (decrease) in cash and cash equivalents

218,000

(1,253,000)Cash and cash equivalents, beginning of period

4,689,000

3,794,000Cash and cash equivalents, end of period

$4,907,000

$2,541,000Supplemental InformationCash payments for interest

$11,000

$68,000Cash payments for income taxes

-

$55,000
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2012 First Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Named One of the Fastest Growing Public Companies in Orange County
3. Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Results
4. Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
6. Pro-Dex, Inc. Announces Fiscal 2011 Third Quarter Financial Results Conference Call and Webcast
7. Pro-Dex, Inc. Announces Fiscal Second Quarter and Six Month Results
8. Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer
9. Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
10. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
11. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... LONDON , Dec. 8, 2016 Australia ... GlobalData,s new report, "Australia Ophthalmic Lasers Market Outlook to ... Lasers market. The report provides value, in millions of ... within market segements - Excimer Lasers, Femtosecond Lasers and ... and distribution shares data for each of these market ...
(Date:12/8/2016)... 2016  The global biosurgery market is expected to ... period of 2016 to 2021. The market is poised ... 18.21 billion in 2016. The market is primarily driven ... related injuries and spinal problems, increasing clearance of biosurgery ... blood loss management. In this report, the ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Groth Family ... Pasco and Richland, is initiating a charity drive to support the family of ... recent automobile collision. , On October 29th of this year, Cindy Hendrickson ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... its 10th anniversary with the grand opening of the Sober College Robert Pfeifer ... spanned two days, December 2-3, and was attended by an overwhelming amount of ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to get ... thought that if the nebulizer had a more child-friendly design, then children would be ... developed the patent-pending NEBY to avoid the need to deliver medication via a nebulizer ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
Breaking Medicine News(10 mins):